Matthew D. Alves

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “MULTIMODAL NUCLEAR FACTOR-ERYTHROID-2–RELATED FACTOR (NRF2) THERAPY IN THE CONTEXT OF MAMMALIAN TARGET OF RAPAMYCIN (MTOR) INHIBITION REPROGRAMS THE ACUTE SYSTEMIC AND PULMONARY IMMUNE RESPONSE AFTER COMBINED BURN AND INHALATION INJURY”.

MULTIMODAL NUCLEAR FACTOR-ERYTHROID-2–RELATED FACTOR (NRF2) THERAPY IN THE CONTEXT OF MAMMALIAN TARGET OF RAPAMYCIN (MTOR) INHIBITION REPROGRAMS THE ACUTE SYSTEMIC AND PULMONARY IMMUNE RESPONSE AFTER COMBINED BURN AND INHALATION INJURY

Shock(2024)10.1097/shk.0000000000002466

N/A

0DataRank · unranked

1 citations

Ryan Clark, Denise A. Hernandez, Madelyn P. Bucci, Duo Chen, Philip A. Efron +4 more

Opposing roles for myeloid and smooth muscle cell STING in pulmonary hypertension

JCI Insight(2025)10.1172/jci.insight.184792

N/A

0DataRank · unranked

2 citations

S.T. Virk, Aline C. Oliveira, Matthew D. Alves, Chunhua Fu, Yutao Zhang +16 more